Biktarvy 50 mg/200 mg/25 mg FILM-COATED TABLETS
PDF Leaflet Revision Date: 19 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults and children over 6 years.
Dosage (summary)
One tablet once daily, with or without food.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Use during pregnancy requires monitoring; not recommended for breastfeeding.
Key Drug Interactions
- Dofetilide
- Rifampicin
- St. John's wort
Contraindications
- Hypersensitivity to components
- Severe hepatic impairment
Common side effects
- Headache
- Diarrhoea
- Nausea
Counselling Points
- Take missed dose within 18 hours
- Monitor for signs of lactic acidosis
- Avoid breastfeeding while on treatment
Serious warnings
- Lactic acidosis
- Hepatotoxicity
- Immune reactivation syndrome
Important Disclaimer
The Biktarvy 50 mg/200 mg/25 mg FILM-COATED TABLETS professional information leaflet below is the property of Gilead Sciences South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
